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ABSTRACT
The CFTR chloride channel is tightly regulated by phosphorylation at multiple serine residues.
Recently it has been proposed that its activity is also regulated by tyrosine kinases, however the
tyrosine phosphorylation sites remain to be identified. In this study we examined 2 candidate
tyrosine residues near the boundary between the first nucleotide binding domain and the R
domain, a region which is important for channel function but devoid of PKA consensus sequences.
Mutating tyrosines at positions 625 and 627 dramatically reduced responses to Src or Pyk2 without
altering the activation by PKA, suggesting they may contribute to CFTR regulation.
KEYWORDS
CFTR regulation; cystic
fibrosis; phosphotyrosine;
Pyk2; Src
Introduction
Cystic Fibrosis is caused bymutations in the cystic fibro-
sis transmembrane conductance regulator (CFTR)
anion channel. Like other members of the ATP-binding
cassette (ABC) transporter family, CFTR channel activ-
ity is regulated by the binding and hydrolysis of ATP
molecules by the Nucleotide Binding Domains
(NBDs).1,2 In addition, CFTR catalytic activity is initi-
ated and regulated by phosphorylation of its unique,
intrinsically disordered regulatory region or R-domain.
The phosphorylation state of CFTR is controlled by
both kinases and phosphatases3 and many serines lie
within consensus sequences for phosphorylation by
PKA and PKC.4 Several studies have suggested that
tyrosine kinases may also influence CFTR gating
either directly or indirectly. Direct tyrosine kinase reg-
ulation was suggested by exposing excised membrane
patches to c-Src kinase5 and by the sensitivity of mus-
carinic stimulation of CFTR to tyrosine kinase inhibi-
tors.6 Indirect regulation through a mechanism in
which tyrosine phosphorylation unmasks a potential
Casein Kinase 2 (CK2) phospho-acceptor site
(Ser511) in NBD1 has also been reported.7,8 We
recently reported that that tyrosine phosphorylation
can be a potent and direct (PKA/C-independent)
stimulus for CFTR activation.9 Moreover, we found
that the tyrosine kinases c-Src and Pyk2 are both able
to phosphorylate CFTR on tyrosine residues, and acti-
vate chloride currents which are 80% as large as those
stimulated by PKA.
The serine/threonine phosphorylation sites on
CFTR have been identified10,11 and their contributions
to channel regulation have been characterized in
detail,12-14 however the tyrosine residues that mediate
direct regulation of channel activity remain unknown.
We have attempted to identify these sites using mass
spectrometry but so far that approach has not been
successful despite clear radiolabeling after incubation
with Src and [g-32P]-ATP and detection of a CFTR
band in immunoprecipitates when immunoblots are
probed with anti-phosphotyrosine antibody. In the
present work, we used a site-directed mutagenesis/
functional assay approach, focusing on 2 candidate
tyrosine residues near the c-terminal end of NBD1
(Y625 and Y627). We found that substituting these
2 tyrosine residues with phenylalanine (CFTR-
YY625,627FF mutant) dramatically reduced (but did
not abolish) tyrosine kinase stimulated currents with-
out altering those stimulated by PKA.
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Results
None of the 40 tyrosine residues on CFTR are situated
in canonical strong sites for phosphorylation by Src or
other tyrosine kinases.15 As a first step toward localiz-
ing the critical tyrosines we examined the ability of
Src to phosphorylate CFTR peptide fragments (Fig. 1).
Polypeptides corresponding to full-length CFTR (a.a.
1-1480, lane 1and2), first membrane domain C NBD1
(a.a. 1-640, lane 3&4), first membrane domain C
NBD1 C R domain (a.a. 1-830, lane 5&6) or all of the
CFTR sequence that is distal to the fourth transmem-
brane segment (a.a. 281-1480, lane 7&8) were stably
expressed in BHK cells. Peptides were immunopreci-
pitated from the control (¡) or v-Src expressing (C)
cells using a mouse monoclonal antibody against anti-
phosphotyrosine, and immunoblots were probed with
the anti-CFTR antibody L12B4. When co-expressed
with the consitutively active tyrosine kinase v-Src, all
CFTR peptides could be immunoprecipitated by anti-
phosphotyrosine antibody as indicated by bands at
their predicted molecular weights (Fig. 1 black
arrows). Tyrosine phosphorylation of all 3 peptides
might be explained by the phosphorylation of one or
more tyrosines between a.a. 281-640, the region of
CFTR which is shared by these peptides, which we
refer to as the “optimistic hypothesis”. Alternatively,
the results are also consistent with the presence of
multiple phosphotyrosines distributed throughout the
molecule.
We tested the optimistic hypothesis (i.e., that
phosphotyrosine is detectable on all the peptides
because it is situated in the region of overlap) by
substituting the most likely candidate tyrosine resi-
dues, Y625 and Y627, simultaneously with phenylala-
nine. Silent patches were excised from BHK stably
expressing the double mutant (CFTR-YY625,627FF)
and exposed to active phospho-Src or to the catalytic
domain of Pyk2 (30U/ml for both kinases). Wt-
CFTR current was strongly activated by both tyrosine
kinases. Figure 2A and B show representative traces
of wt-CFTR activity induced by Src and Pyk2, respec-
tively. By contrast, CFTR channel activation by the 2
tested tyrosine kinases was strongly decreased in the
double mutant compared to the normal responses to
PKA (75 nM), which was added at the end of each
experiment (Fig. 2C and D). Strong activation by
PKA confirmed the presence of mutant CFTR chan-
nels in the patch and indicate that substituting phe-
nylalanine at Y625 and Y627 did not grossly affect
channel function.
To compare the activation by different kinases we
added the non-hydrolysable ATP analog AMP-PNP
(1mM) at the end of experiments and calculated the
current ratio to help normalize for variation in the
number of channels per patch as described previ-
ously.9 Figure 2E shows a histogram of the current
ratios obtained in presence of 30U/ml Src, Pyk2, or
75nM PKA. The ratios revealed a dramatically
decrease in the activation of YY625,627FF CFTR by
Src or Pyk2 (current ratios 0.20 and 0.13 respectively,
n D 3) compared to wild-type CFTR. This contrasted
with the current ratio during application of PKA,
which was similar for mutant (current ratio 0.51,
n D 5) and wild-type channels. These data strongly
suggest that phosphorylation of one or both tyrosines
contributes to CFTR activation by Src and Pyk2,
although part (25 – 40%) of the response is apparently
due to other sites which remain to be identified.
Figure 1. Phosphorylation of CFTR by Src kinase. Blot of anto-
phosphotyrosine immunoprecipitates probed with the anti-CFTR
monoclonal antibody L12B4. CFTR peptides (identified by the
boundary amino acid numbers indicated above each pair of
lanes) co-expressed with or without v-Src and precipitated using
monoclonal antibody against phosphotyrosine. Black arrows indi-
cate the positions of CFTR phosphopeptides. The bands at~50 and
~100 kDa observed in every lane indicate mono- and dimeric
heavy chains of the immunoprecipitating IgG, which are recog-
nized by the secondary antibody used for immunoblotting. Black
arrows indicate CFTR fragments. A representative of 2 experi-
ments is shown.
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Discussion
In a previous study we found that the tyrosine kinases
Src and Pyk2 can activate wild-type CFTR, producing
currents that reach 80% of those stimulated by PKA.9
Here we observed a dramatic decrease in tyrosine
kinase-activated currents when Y625 and Y627 were
mutagenized to phenylalanine (YY625,627FF) in full-
length CFTR. Since PKA stimulation was not altered
in the double mutant, one or both tyrosine residues
may contribute to CFTR activation by tyrosine
kinases.
As a first approach toward localizing the site we
coexpressed peptides corresponding to different
regions of CFTR together with v-Src and examined
their in vivo phosphorylation by immunoprecipitation
with anti-phosphotyrosine antibody and blotting with
anti-CFTR antibody. Phosphotyrosine was detected
on all 3 peptides, therefore we focused on tyrosines in
the region of overlap (amino acids 281 – 640), which
occur in the sequence KILI[LHEGSSY625]FY627GTF.
Based on the preferential phosphorylation of
sequences in a peptide library, E(2-3)-I/V-Y- G/
Figure 2. Effect of Src and Pyk2 on activity of the CFTR double mutant YY625,627FF. (A–D): Effect of Src (A & C) and Pyk2 (B & D) on
channel activity in patch excised from cell expressing wt (A&B) or YY625,627FF (C & D) CFTR. (E): Comparison of the mean ratio of the
kinase- stimulated currents measured before and after addition of 1 mM AMP-PNP. Error bars show SE for number of cells indicated. ,
p< 0.05; , p< 0.01 with student t-test. The wt-CFTR results from Billet et al 20159 obtained under identical conditions are reproduced
here for comparison with YY625,627FF-CFTR mutant.
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E-X-F15 was proposed to be the ideal Src consensus.
The three residues following Y627 fit this consensus,
however the non-polar residue and 2 or 3 upstream
glutamates are lacking. This divergence from the ideal
consensus may explain why high activity, i.e., heterol-
ogous expression of constitutively active v-Src, was
needed to be able to detect tyrosine phosphorylation
in intact cells. We cannot exclude other explanations
however as the specificity may depend on factors other
than the primary sequence, and Src kinases are known
to phosphorylate a range of target sequences.16 The
sequence upstream of Y625 and Y627 bears some
resemblance to the generic protein tyrosine kinase
(PTK) consensus R/K-[X(2/3)-D/E-X(3/2)-Y], sug-
gesting these sites in CFTR might also be a substrates
for other tyrosine kinases under physiological condi-
tions. The lack of PKA sites near these sites reinforce
the notion that phosphotyrosine acts specifically
rather than as a surrogate for phosphoserine.
Interestingly, Y625 and Y627 are situated at the
junction between NBD1 and the R domain, a region
in which structural integrity is crucial for channel reg-
ulation and pharmacology.17,18 Further studies of
tyrosine kinase regulation may provide a better
understanding of R domain structure and the confor-
mational changes associated with CFTR channel
regulation.
Methods
Plasmid and cell culture
Baby hamster kidney (BHK) cells stably expressing
wild-type CFTR or the YY625,627FF-CFTR mutant10
were plated on plastic coverslips at low density and cul-
tured in MEM (Life Technologies, Burlington, ON,
Canada) containing 5% FBS and the selecting drug
methotrexate (300-500 mM) for 2 days with 5% CO2 at
37C. To express peptides comprising different regions
of CFTR, cDNAs encoding amino acids 1-640, 1-830,
and 281- 1480 were prepared by PCR mutagenesis,
inserted into the pNUT vector, and stably transfected
into BHK cells. The role of tyrosines 625 and 627 of
CFTR in the activation by Src was examined by substi-
tuting them with phenylalanines using site-directed
mutagenesis. An expression plasmid containing v-Src
cDNA was kindly provided by Dr. R. Huganir (Depart-
ment of Neuroscience, Johns Hopkins University) and
co-transfected with large T antigen plasmid into BHK
cells using calcium phosphate co-precipitation.
Tyrosine phosphorylation
To detect phosphotyrosine on CFTR, cells in 25 cm2
dishes were transiently transfected using calcium phos-
phate coprecipitation with 5 mg of v-Src plasmid DNA
and 1 mg of a large T-antigen expressing plasmid. Two
days after Src transfection, cells were lysed in RIPA
buffer and subjected to sequential immunoprecipitation
and immunoblotting. For immunoprecipitation we
used an anti-phosphotyrosine monoclonal antibody,
which recognizes an epitope between residues 1365 and
1395 of CFTR. The monoclonal antibody L12B4, which
recognizes an epitope between residues 386 and 412 of
CFTR, was used for immunoblotting.
Patch clamp
Microscopic CFTR currents were recorded from
inside-out patches as previously described.9 The ratio
of currents activated by kinase in the absence vs pres-
ence of AMP-PNP (which further increases open
probability to near Po D 1.0) allowed CFTR
responses to be normalized for variations in the
number of channels per patch. Recombinant Src
(30U/ml) was from EMD Millipore; the catalytic
domain of Pyk2(30U/ml) was from Cedarlane (Bur-
lington, ON, Canada); PKA (final concentration,
75 nM–30 U) was from Promega (Madison, WI,
USA); MgATP (1 mM) was from Sigma-Aldrich, and
AMP-PNP (1 mM) was from Sigma-Aldrich (St.
Louis, MO, USA).
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